Back to overview

CVE-2026-48282

CRITICAL KEV CISA Exploitation: ACTIVE
10.0
CVSS 3.1
Description
ColdFusion versions 2025.9, 2023.20 and earlier are affected by an Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability that could lead to arbitrary code execution in the context of the current user. Exploitation of this issue does not require user interaction. Scope is changed.

Metadata

CVE ID
CVE-2026-48282
State
PUBLISHED
Assigner
adobe
Reserved
2026-05-21 15:28 UTC
Published
2026-06-30 15:11 UTC
Last updated
2026-07-08 03:56 UTC
Primary CWE
CWE-22
Improper Limitation of a Pathname to a Restricted Directory …
Vendor / Product
Adobe / ColdFusion
Sources
cve.org  ·  NVD

Severity & Metrics

10.0 CRITICAL CVSS 3.1
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
SSVC — CISA Coordinator
Exploitation
ACTIVE
Automatable
yes
Tech. Impact
total
CISA Known Exploited Vulnerability
Vulnerability name
Adobe ColdFusion Path Traversal Vulnerability
Vendor
Adobe
Product
ColdFusion
Added to KEV
2026-07-07
Due date
2026-07-10
Ransomware
Not known
Required action
Apply mitigations in accordance with vendor instructions, ensuring compliance with CISA’s BOD 26-04 Prioritizing Security Updates Based on Risk (see URL in Notes) guidance and CISA’s “Forensics Triage Requirements” (see URL in Notes). Follow applicable BOD 26-04 guidance for cloud services or discontinue use of the product if mitigations are unavailable. Stakeholders are responsible for evaluating each asset's internet exposure and ensuring adherence to BOD 26-04 patching guidelines.
CISA description
Adobe ColdFusion contains a path traversal vulnerability that could lead to arbitrary code execution in the context of the current user.
Affected products (1)
VendorProductPlatformVersions
Adobe ColdFusion — 0 ≤ 2023.20
Weakness (CWE)
CWESourceDescription
CWE-22 cna Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') (CWE-22)
CVSS scores (1)
ScoreSeverityVersionSourceVector
10.0 CRITICAL 3.1 cna CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
Back to overview